Choice Hotels International, Inc. (CHH - Free Report) , which banks on solid brand presence and continual expansion for growth, has announced the opening of a hotel in greater Portland, OR. Notably, this opening marks the company’s 250th hotel under its WoodSpring Suites brand and the first in the state of Oregon.
The company is quite confident about the success of this hotel as Portland is a business-friendly city. The 122 room WoodSpring hotel is a short drive from many universities, hospitals and corporate offices like Nike, Boeing, and Lithia Motors Inc. and subsidiaries of Intel, eBAY as well as Hewlett-Packard.
Ever since the acquisition of WoodSpring Suites in February 2018, extended-stay hotels have doing exceptionally well. The buyout helped RevPAR to grow by 7.6% in 2018 outpacing the industry by 470 basis points. Currently, the company has 117 hotels under its pipeline. Patrick Pacious, president and CEO of Choice Hotels said that “The WoodSpring Suites brand has seen significant business delivery growth nearly every month since the acquisition.”
In 2019, the WoodSpring Suites brand anticipates to open approximately 20 hotels in Miami and Orlando, FL, Sacramento, CA, and San Antonio. By the end of 2020, Choice Hotels expects to have 300 WoodSpring Suites hotels.
Meanwhile, management continues to expand its international footprint in new countries alongside domestic growth. In April, Choice Hotels announced a strategic alliance with Sercotel — a leading hotel operator and franchisor based in Spain. This alliance will enable the expansion of Choice Hotels’ global footprint in Spain and other markets as well as create opportunities for additional hotel development across Europe and Latin America.
Driven by its expansion strategy, shares of Choice Hotels have gained 12.3% year to date compared with the industry’s 8.2% growth.
Choice Hotels, which shares space with Extended Stay America, Inc. (STAY - Free Report) and Marriott Vacations Worldwide Corporation (VAC - Free Report) , has a Zacks Rank #3 (Hold).
A better-ranked stock in the same space includes Belmond Ltd. , sporting a Zacks Rank #1 (Strong Buy). The company delivered better-than-expected earnings in the trailing two quarters. You can see the complete list of today’s Zacks #1 Rank stocks here.
3 Medical Stocks to Buy Now
The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.
So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.
See them today for free >>